Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

The Crux of Ebola Diagnostics.

Strong JE, Feldmann H.

J Infect Dis. 2017 Dec 12;216(11):1340-1342. doi: 10.1093/infdis/jix490. No abstract available.

2.

Delivering Prolonged Intensive Care to a Non-human Primate: A High Fidelity Animal Model of Critical Illness.

Poliquin PG, Biondi M, Ranadheera C, Hagan M, Bello A, Racine T, Allan M, Funk D, Hansen G, Hancock BJ, Kesselman M, Mortimer T, Kumar A, Jones S, Leung A, Grolla A, Tran KN, Tierney K, Qiu X, Kobasa D, Strong JE.

Sci Rep. 2017 Apr 26;7(1):1204. doi: 10.1038/s41598-017-01107-6.

3.

Reply to Colebunders.

Rosenke K, Adjemian J, Munster VJ, Strong JE, Sprecher A, Feldmann H, de Wit E.

Clin Infect Dis. 2017 Jan 15;64(2):232. doi: 10.1093/cid/ciw734. Epub 2016 Nov 9. No abstract available.

4.

Plasmodium Parasitemia Associated With Increased Survival in Ebola Virus-Infected Patients.

Rosenke K, Adjemian J, Munster VJ, Marzi A, Falzarano D, Onyango CO, Ochieng M, Juma B, Fischer RJ, Prescott JB, Safronetz D, Omballa V, Owuor C, Hoenen T, Groseth A, Martellaro C, van Doremalen N, Zemtsova G, Self J, Bushmaker T, McNally K, Rowe T, Emery SL, Feldmann F, Williamson BN, Best SM, Nyenswah TG, Grolla A, Strong JE, Kobinger G, Bolay FK, Zoon KC, Stassijns J, Giuliani R, de Smet M, Nichol ST, Fields B, Sprecher A, Massaquoi M, Feldmann H, de Wit E.

Clin Infect Dis. 2016 Oct 15;63(8):1026-33. doi: 10.1093/cid/ciw452. Epub 2016 Aug 15.

5.

Environmental Contamination and Persistence of Ebola Virus RNA in an Ebola Treatment Center.

Poliquin PG, Vogt F, Kasztura M, Leung A, Deschambault Y, Van den Bergh R, Dorion C, Maes P, Kamara A, Kobinger G, Sprecher A, Strong JE.

J Infect Dis. 2016 Oct 15;214(suppl 3):S145-S152. Epub 2016 Jun 30.

PMID:
27365495
6.

Ebola Laboratory Response at the Eternal Love Winning Africa Campus, Monrovia, Liberia, 2014-2015.

de Wit E, Rosenke K, Fischer RJ, Marzi A, Prescott J, Bushmaker T, van Doremalen N, Emery SL, Falzarano D, Feldmann F, Groseth A, Hoenen T, Juma B, McNally KL, Ochieng M, Omballa V, Onyango CO, Owuor C, Rowe T, Safronetz D, Self J, Williamson BN, Zemtsova G, Grolla A, Kobinger G, Rayfield M, Ströher U, Strong JE, Best SM, Ebihara H, Zoon KC, Nichol ST, Nyenswah TG, Bolay FK, Massaquoi M, Feldmann H, Fields B.

J Infect Dis. 2016 Oct 15;214(suppl 3):S169-S176. Epub 2016 Jun 21.

7.

The Merits of Malaria Diagnostics during an Ebola Virus Disease Outbreak.

de Wit E, Falzarano D, Onyango C, Rosenke K, Marzi A, Ochieng M, Juma B, Fischer RJ, Prescott JB, Safronetz D, Omballa V, Owuor C, Hoenen T, Groseth A, van Doremalen N, Zemtsova G, Self J, Bushmaker T, McNally K, Rowe T, Emery SL, Feldmann F, Williamson B, Nyenswah TG, Grolla A, Strong JE, Kobinger G, Stroeher U, Rayfield M, Bolay FK, Zoon KC, Stassijns J, Tampellini L, de Smet M, Nichol ST, Fields B, Sprecher A, Feldmann H, Massaquoi M, Munster VJ.

Emerg Infect Dis. 2016 Feb;22(2):323-6. doi: 10.3201/eid2202.151656.

8.

Ebola viral load at diagnosis associates with patient outcome and outbreak evolution.

de La Vega MA, Caleo G, Audet J, Qiu X, Kozak RA, Brooks JI, Kern S, Wolz A, Sprecher A, Greig J, Lokuge K, Kargbo DK, Kargbo B, Di Caro A, Grolla A, Kobasa D, Strong JE, Ippolito G, Van Herp M, Kobinger GP.

J Clin Invest. 2015 Dec;125(12):4421-8. doi: 10.1172/JCI83162. Epub 2015 Nov 9.

9.

EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain.

Marzi A, Robertson SJ, Haddock E, Feldmann F, Hanley PW, Scott DP, Strong JE, Kobinger G, Best SM, Feldmann H.

Science. 2015 Aug 14;349(6249):739-42. doi: 10.1126/science.aab3920. Epub 2015 Aug 6.

10.

Correction for Osterholm et al., Transmission of Ebola Viruses: What We Know and What We Do Not Know.

Osterholm MT, Moore KA, Kelley NS, Brosseau LM, Wong G, Murphy FA, Peters CJ, LeDuc JW, Russell PK, Van Herp M, Kapetshi J, Muyembe JJ, Ilunga BK, Strong JE, Grolla A, Wolz A, Kargbo B, Kargbo DK, Sanders DA, Kobinger GP.

MBio. 2015 Jul 21;6(4):e01154. doi: 10.1128/mBio.01154-15. No abstract available.

11.

Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection.

Geisbert TW, Strong JE, Feldmann H.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S91-7. doi: 10.1093/infdis/jiv284. Epub 2015 Jun 10.

12.

Evaluating environmental persistence and disinfection of the Ebola virus Makona variant.

Cook BW, Cutts TA, Nikiforuk AM, Poliquin PG, Court DA, Strong JE, Theriault SS.

Viruses. 2015 Apr 14;7(4):1975-86. doi: 10.3390/v7041975.

13.

Transmission of Ebola viruses: what we know and what we do not know.

Osterholm MT, Moore KA, Kelley NS, Brosseau LM, Wong G, Murphy FA, Peters CJ, LeDuc JW, Russell PK, Van Herp M, Kapetshi J, Muyembe JJ, Ilunga BK, Strong JE, Grolla A, Wolz A, Kargbo B, Kargbo DK, Sanders DA, Kobinger GP.

MBio. 2015 Feb 19;6(2):e00137. doi: 10.1128/mBio.00137-15. Review. Erratum in: MBio. 2015;6(4):e01154. Formenty, Pierre [Deleted].

14.

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp.

Qiu X, Wong G, Audet J, Bello A, Fernando L, Alimonti JB, Fausther-Bovendo H, Wei H, Aviles J, Hiatt E, Johnson A, Morton J, Swope K, Bohorov O, Bohorova N, Goodman C, Kim D, Pauly MH, Velasco J, Pettitt J, Olinger GG, Whaley K, Xu B, Strong JE, Zeitlin L, Kobinger GP.

Nature. 2014 Oct 2;514(7520):47-53. doi: 10.1038/nature13777. Epub 2014 Aug 29.

15.

A recently isolated Lassa virus from Mali demonstrates atypical clinical disease manifestations and decreased virulence in cynomolgus macaques.

Safronetz D, Strong JE, Feldmann F, Haddock E, Sogoba N, Brining D, Geisbert TW, Scott DP, Feldmann H.

J Infect Dis. 2013 Apr 15;207(8):1316-27. doi: 10.1093/infdis/jit004. Epub 2013 Jan 9.

16.

Recently emerged swine influenza A virus (H2N3) causes severe pneumonia in Cynomolgus macaques.

Richt JA, Rockx B, Ma W, Feldmann F, Safronetz D, Marzi A, Kobasa D, Strong JE, Kercher L, Long D, Gardner D, Brining D, Feldmann H.

PLoS One. 2012;7(7):e39990. doi: 10.1371/journal.pone.0039990. Epub 2012 Jul 11.

17.

Evaluation of Different Strategies for Post-Exposure Treatment of Ebola Virus Infection in Rodents.

Richardson JS, Wong G, Pillet S, Schindle S, Ennis J, Turner J, Strong JE, Kobinger GP.

J Bioterror Biodef. 2011 Oct 20;(S1). pii: 007.

18.

Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus.

Falzarano D, Feldmann F, Grolla A, Leung A, Ebihara H, Strong JE, Marzi A, Takada A, Jones S, Gren J, Geisbert J, Jones SM, Geisbert TW, Feldmann H.

J Infect Dis. 2011 Nov;204 Suppl 3:S1082-9. doi: 10.1093/infdis/jir350.

19.

The use of a mobile laboratory unit in support of patient management and epidemiological surveillance during the 2005 Marburg Outbreak in Angola.

Grolla A, Jones SM, Fernando L, Strong JE, Ströher U, Möller P, Paweska JT, Burt F, Pablo Palma P, Sprecher A, Formenty P, Roth C, Feldmann H.

PLoS Negl Trop Dis. 2011 May;5(5):e1183. doi: 10.1371/journal.pntd.0001183. Epub 2011 May 24.

20.

Factors associated with Marburg hemorrhagic fever: analysis of patient data from Uige, Angola.

Roddy P, Thomas SL, Jeffs B, Nascimento Folo P, Pablo Palma P, Moco Henrique B, Villa L, Damiao Machado FP, Bernal O, Jones SM, Strong JE, Feldmann H, Borchert M.

J Infect Dis. 2010 Jun 15;201(12):1909-18. doi: 10.1086/652748.

Supplemental Content

Loading ...
Support Center